Understanding the Policy Driving Historic Drug Savings
At Valley Integrated Urgent Care & Wellness Center, our mission is to ensure our community has access to the best health outcomes. A critical barrier to health management has always been the exorbitant cost of essential medications. That is why we are providing this vital overview of the Most-Favored-Nation (MFN) Pricing policy, recently rolled out by the Trump Administration, and the profound impact it will have on American patients.
This new policy, implemented via TrumpRx, finalizes agreements with major manufacturers, including Eli Lilly and Novo Nordisk, to dramatically align U.S. drug prices with those paid by other wealthy nations.



Dramatic Price Drops on Popular Medications
The most significant changes target medications used to treat some of America’s most widespread chronic conditions: obesity, diabetes, and related heart diseases.
The negotiated prices, when purchased through TrumpRx, represent immediate, life-changing relief for many patients:
These reductions make powerful tools for managing diabetes and weight accessible to millions more Americans.
New Medicare Coverage and Chronic Disease Management
One of the most impactful developments is the expansion of coverage for obesity and related comorbidities under Medicare.
The Centers for Disease Control and Prevention (CDC) estimates that over 40% of American adults struggle with obesity, which is a key driver for conditions like Type 2 diabetes, heart disease, and hypertension.
This is a historic step in helping the nation address the root causes of chronic disease, moving toward a goal of Making America Healthy Again.


Additional Key Savings and Investment
The MFN pricing agreement extends savings across several other crucial medications:
| Medication | Condition Treated | New TrumpRx Price | Savings (Off List Price) |
|---|---|---|---|
| Insulin Products (NovoLog, Tresiba) | Diabetes | $35 per month of supply | Significant |
| Trulicity | Diabetes | $389 per month | $598 off list price |
| Emgality | Migraines | $299 per pen | $443 off list price |
In addition to patient savings, the policy mandates that manufacturers like Novo Nordisk and Eli Lilly guarantee MFN prices on all new medicines and commit to massive U.S. manufacturing investments (exceeding $37 billion combined). This secures the supply chain while protecting American patients from paying the highest prices globally.
Your Health: Next Steps with Valley Integrated Wellness Center
While this new policy offers unprecedented financial relief, managing chronic conditions like obesity, diabetes, and migraines still requires personalized medical guidance.
The MFN policy empowers you to afford the medication you need. Valley Integrated Wellness Center is here to partner with you on a comprehensive health plan that includes necessary lifestyle changes, regular monitoring, and prescription management.
Take Action Today!



